Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India, Developing Nations To Press Third-World Disease Drugs At WHO Meeting (India)

This article was originally published in PharmAsia News

Executive Summary

India and other developing nations plan to make a strong case in an April international lobbying effort for funding drugs aimed at some of the diseases plaguing their segment of the world. Diseases in the developing world, such as tuberculosis and malaria, comprise less than 10 percent of research dollars spent on drug research even though those diseases account for more than 90 percent of the diseases afflicting the world's population. The World Health Organization's decision-making body has scheduled international negotiations in Switzerland in April to hear from participating nations on the issue. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts